Page 38 - Read Online
P. 38

Page 12 of 20          Nwaiwu et al. Mini-invasive Surg. 2025;9:20  https://dx.doi.org/10.20517/2574-1225.2024.112














































                                            [37]
                Figure 3. Absorption-limiting interventions  . (A) DJBL (EndoBarrier); (B) GJBS; (C) IMAS. DJBL: Duodenojejunal bypass liner; GJBS:
                gastroduodenojejunal bypass sleeve; IMAS: incisionless magnetic anastomotic system.

               esophageal leak or death was noted during the study . This device has not received FDA approval.
                                                           [64]
               Incisionless magnetic anastomotic system
               The incisionless magnetic anastomotic system (IMAS; GI Windows, West Bridgewater, MA) uses self-
               assembling magnets to create a side-to-side anastomosis between the proximal jejunum and the terminal
               ileum. Delivered endoscopically via colonoscopy and upper endoscopy in a linear configuration
               (sometimes, with laparoscopic supervision), the magnets reconfigure into a large-caliber octagon, forming a
               bypass larger than traditional endoscopic methods allow [Figure 3C] . After several days (8-28 days), the
                                                                          [37]
               magnets are expelled naturally through the stool. This creates a partial jejunoileal bypass that reroutes bile
               acids and nutrients to the ileum, reducing nutrient absorption . A small pilot study demonstrated an
                                                                      [65]
               average TBWL of 14.6% (40.2% EWL) at 12 months post-procedure and a significant decrease in
               hemoglobin A1c (HbA1c) in both diabetic (1.9%) and prediabetic (1.0%) patients with decreased use or
               discontinuation of antihyperglycemic medications. There was a 23% reduction in alanine aminotransferase
               values from the baseline . FDA approval is pending.
                                   [65]

               Magnetic anastomosis system
                                                                                          [66]
               The magnetic anastomosis system (MS; GT Metabolic Solutions, San Jose, CA, Figure 4 ) is intended for
               use in the creation of a side-to-side duodeno-ileal (DI) anastomosis  in patients with prior SG (MagDI-
                                                                          [66]
   33   34   35   36   37   38   39   40   41   42   43